“Several unique opportunities to perform studies and evaluations of a range of therapeutic and preventive interventions at the peak of the SARS and MERS outbreaks were lost due to delays,” explains Professor Ali Zumla (UCL Infection & Immunity).
Read: Globe & Mail
Close
